| Multipeptide Vaccine for Advanced Breast Cancer (NCT00573495) | University of Pennsylvania | 2007-11-01 |
| FDG-PET/CT for Simulation and Radiation Treatment Planning of Early Breast Cancer (NCT01432002) | University Hospital, Geneva | 2007-11-01 |
| Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast Cancer (NCT00530868) | University of Alabama at Birmingham | 2007-10-08 |
| Yoga to Reduce Cancer Fatigue (NCT00583739) | University of Iowa | 2007-08-01 |
| Phase II Trial to Compare the Safety of Two Chemotherapy Plus Trastuzumab Regimens as Adjuvant Therapy for HER2-positive Breast Cancer (Study P05048) (NCT00550771) | Merck Sharp & Dohme LLC | 2007-07-16 |
| Post-treatment Care of Breast Cancer Survivors (NCT00821288) | Columbia University | 2007-07-01 |
| Cetuximab and Cisplatin in the Treatment of "Triple Negative" (Estrogen Receptor [ER] Negative, Progesterone Receptor [PgR] Negative, and Human Epidermal Growth Factor Receptor 2 [HER2] Negative) Metastatic Breast Cancer (NCT00463788) | Merck KGaA, Darmstadt, Germany | 2007-06-01 |
| A Study to Evaluate Safety and Tolerability in Patients With Metastatic Breast Cancer Receiving Treatment With Caelyx (Study P04878)(COMPLETED) (NCT00736333) | Merck Sharp & Dohme LLC | 2006-11-01 |
| Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer (NCT00313248) | Bayer | 2006-04-01 |
| Strength Training for Older Breast Cancer Survivors (NCT00591747) | OHSU Knight Cancer Institute | 2005-11-01 |
| A Study of MLN8054 in Patients With Advanced Solid Tumors (NCT00249301) | Millennium Pharmaceuticals, Inc. | 2005-10-01 |
| Comparison of Safety and Efficacy of TOCOSOL(R) Paclitaxel Versus Taxol(R) for Treatment of Metastatic Breast Cancer (NCT00251095) | Achieve Life Sciences | 2005-09-01 |
| A Study to Determine the Activity of Caelyx With Trastuzumab and Docetaxel in the Treatment of Metastatic Breast Cancer (Study P03679) (NCT00687440) | Merck Sharp & Dohme LLC | 2005-07-15 |
| GenetiKiT: Evaluation of an Educational Intervention on the Delivery of Genetics Services by Family Physicians (NCT00295529) | University of Toronto | 2005-04-01 |
| Weekly Taxol Plus Xeloda® vs Taxotere q3wk Plus Xeloda® in the Treatment of Metastatic BC (NCT00201435) | Norwegian Breast Cancer Group | 2005-03-01 |
| Everolimus and Letrozole as Preoperative Therapy of Primary Breast Cancer in Post-menopausal Women (NCT00107016) | Novartis Pharmaceuticals | 2005-03-01 |
| A Study to Evaluate Safety and Efficacy of Caelyx in Combination With Cyclophosphamide in the Treatment of Metastatic Breast Cancer (P02948) (NCT00779129) | Merck Sharp & Dohme LLC | 2003-03-01 |
| Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2 (NCT00034281) | Takeda | 2002-06-01 |
| Weekly Vinorelbine and Oral Capecitabine as Treatment for Stage IV Breast Cancer (NCT00194727) | University of Washington | 2002-05-01 |
| Adjuvant Therapy for High-Risk Breast Cancer With Wkly Adriamycin & Oral Cytoxan With G-CSF for 12 Wks; Wkly Taxol x 12 (NCT00194753) | University of Washington | 2001-12-01 |
| Primary Chemotherapy With Docetaxel-Capecitabine and Doxorubicin-Cyclophosphamide in Breast Cancer (NCT00005908) | National Cancer Institute (NCI) | 2000-06-01 |
| Combination Therapy of Interleukin-12 and Interleukin-2 to Treat Advanced Cancer (NCT00005655) | National Cancer Institute (NCI) | 2000-04-28 |
| Microarray Analysis for Human Genetic Disease (NCT00001898) | National Human Genome Research Institute (NHGRI) | 1999-06-29 |
| Application Of Epirubicin Within A Neo-/Adjuvant Chemotherapy In Patients With Primary Breast Cancer (NCT01061359) | Pfizer | 1999-01-01 |
| Effects of Raloxifene on the Uterus and Ovaries of Premenopausal Patients (NCT00001837) | National Institutes of Health Clinical Center (CC) | 1998-11-01 |
| Taxotere Plus Weekly Navelbine and G-CSF: A Study in Stage IV Breast Cancer (NCT00194740) | University of Washington | 1997-11-01 |
| Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast Cancer (NCT00001507) | National Cancer Institute (NCI) | 1996-07-12 |
| A Phase I Trial of Tamoxifen and 9-Cis-Retinoic Acid in Breast Cancer Patients (NCT00001504) | National Cancer Institute (NCI) | 1996-05-01 |
| Establishment of Normal Breast Epithelial Cell Lines From Patients at High Risk for Breast Cancer (NCT00001496) | National Cancer Institute (NCI) | 1996-01-01 |
| Autologous T-Cell Transplantation and the Immunotherapy of Residual Disease in Breast Cancer: Pilot Study of Vaccine-Driven T-Cell Expansion in Patients Treated With Dose-Intensive Chemotherapy (NCT00001440) | National Cancer Institute (NCI) | 1995-07-01 |